Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : TELK -- Telik, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (264)	2/26/2002 2:09:48 PM
From: Tomato	Respond to of 887

Thanks. eom

To: scaram(o)uche who wrote (264)	2/28/2002 12:52:28 PM
From: keokalani'nui	Read Replies (1) \| Respond to of 887

Large holder of kosn too I see. Raising some money everywhere these days. With some management changes at kosn....I just get so jumpy. Wilder

To: scaram(o)uche who wrote (264)	3/28/2002 3:51:23 PM
From: Tomato	Read Replies (2) \| Respond to of 887

I thought I'd look to see if there was an "ASCO effect" on the price of stocks with cancer drug prospects immediately prior and/or subsequent to ASCO (in mid-May, right?). Here's what I came up with using some stocks with cancer links: siliconinvestor.com siliconinvestor.com siliconinvestor.com siliconinvestor.com siliconinvestor.com siliconinvestor.com siliconinvestor.com Here's the BTK.X as a benchmark: siliconinvestor.com Not sure that I see much correlation. But TELK has the phase II results coming out in May, isn't it?